ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 36 filers reported holding ESSA PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,358 | -0.0% | 21,475 | -12.6% | 0.00% | – |
| Q2 2023 | $66,374 | -64.8% | 24,583 | -61.2% | 0.00% | – |
| Q1 2023 | $188,298 | +13.9% | 63,400 | -3.4% | 0.00% | – |
| Q4 2022 | $165,312 | +132.8% | 65,600 | +68.2% | 0.00% | – |
| Q3 2022 | $71,000 | +31.5% | 39,000 | +128.1% | 0.00% | – |
| Q2 2022 | $54,000 | -59.4% | 17,100 | -20.8% | 0.00% | – |
| Q1 2022 | $133,000 | -98.1% | 21,600 | -95.6% | 0.00% | -100.0% |
| Q4 2021 | $7,034,000 | +28.2% | 495,297 | -27.7% | 0.00% | 0.0% |
| Q3 2021 | $5,485,000 | -73.4% | 685,531 | -4.9% | 0.00% | -80.0% |
| Q2 2021 | $20,590,000 | +45.6% | 720,701 | +48.1% | 0.01% | +66.7% |
| Q1 2021 | $14,137,000 | +195.1% | 486,659 | +21.2% | 0.00% | +200.0% |
| Q4 2020 | $4,791,000 | +72.6% | 401,612 | -0.2% | 0.00% | 0.0% |
| Q3 2020 | $2,776,000 | – | 402,344 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 2,070,052 | $60,135,000 | 10.84% |
| Burrage Capital Management LLC | 237,442 | $6,898,000 | 5.59% |
| Asymmetry Capital Management, L.P. | 284,459 | $8,264,000 | 4.28% |
| BVF INC/IL | 2,908,326 | $84,487,000 | 3.17% |
| Stenahm Asset Managment Ltd | 147,113 | $4,274,000 | 3.01% |
| ACUTA CAPITAL PARTNERS, LLC | 287,000 | $8,337,000 | 3.01% |
| Avidity Partners Management LP | 2,840,000 | $82,502,000 | 2.28% |
| Vivo Capital, LLC | 2,068,907 | $60,102,000 | 2.11% |
| COMMODORE CAPITAL LP | 176,821 | $5,137,000 | 2.05% |
| Ally Bridge Group (NY) LLC | 363,185 | $10,551,000 | 2.02% |